Pfizer Reports FDA Acceptance For Review Of SNDA For Oral Xelja By: Benzinga via Benzinga February 04, 2015 at 15:23 PM EST Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New ... Read More >> Related Stocks: Pfizer